Precision BioSciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DTIL research report →
Companywww.precisionbiosciences.com
Precision BioSciences, Inc. , a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders.
- CEO
- Juli Blanche
- IPO
- 2019
- Employees
- 108
- HQ
- Durham, NC, US
Price Chart
Valuation
- Market Cap
- $92.11M
- P/E
- -2.07
- P/S
- 2.04
- P/B
- 1.21
- EV/EBITDA
- -0.68
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 96.95%
- Op Margin
- -86.77%
- Net Margin
- -98.70%
- ROE
- -81.24%
- ROIC
- -28.40%
Growth & Income
- Revenue
- $34.26M · -50.12%
- Net Income
- $-46,609,000 · -750.33%
- EPS
- $-3.63 · -445.71%
- Op Income
- $-52,148,000
- FCF YoY
- -12.32%
Performance & Tape
- 52W High
- $8.82
- 52W Low
- $3.53
- 50D MA
- $6.86
- 200D MA
- $5.44
- Beta
- 1.31
- Avg Volume
- 276.81K
Get TickerSpark's AI analysis on DTIL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 17, 26 | Amoroso Michael | other | 67,797 |
| Feb 18, 26 | Amoroso Michael | sell | 20,559 |
| Feb 17, 26 | Amoroso Michael | other | 67,797 |
| Feb 17, 26 | Kelly John Alexander | other | 27,584 |
| Feb 18, 26 | Kelly John Alexander | sell | 8,149 |
| Feb 17, 26 | Kelly John Alexander | other | 27,584 |
| Feb 17, 26 | Scimeca Dario | other | 16,667 |
| Feb 18, 26 | Scimeca Dario | sell | 4,925 |
| Feb 17, 26 | Scimeca Dario | other | 16,667 |
| Feb 17, 26 | SMITH J. JEFFERSON | other | 16,667 |
Our DTIL Coverage
We haven't published any research on DTIL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DTIL Report →